EUVIMEDEUVIMED entdecken
Crossref

β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models

Yongqiang Xiong, Wu Luo, Jiaxi Ye, Yaqian Cui, Xiangsheng Zheng, Leiming Jin, Shuaijie Lou, Qianhui Zhang, Ao Wang, Yi Fang, Tianyang Jin, Mengsha Lin und 4 weitere

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Yongqiang Xiong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: PPAR alpha, Sesquiterpenes, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Wenzhou Medical Universitity Distinguished Young Scholar Project, Science and Technology Plan Project of Wenzhou Municipality, Zhejiang Provincial Health Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Metabolic dysfunction‐associated steatohepatitis (MASH) is an escalating global health concern with few effective pharmacological treatment options available. β‐elemene (ELE) is a natural product derived from Curcuma Rhizoma , which has anti‐tumour and anti‐inflammatory effects. However, its efficacy and molecular mechanism in MASH have not been elucidated. Experimental Approach Two diet‐induced MASH models were used to evaluate the therapeutic potential of ELE in vivo . Additionally, RNA sequencing, network pharmacological analysis, and target validation were performed to elucidate the underlying mechanisms. Key Results ELE markedly ameliorated lipid dysfunction and the inflammatory response in MASH mice and fatty acids‐stimulated hepatocytes. RNA‐sequencing analysis indicated that ELE exerted its therapeutic effects through activating the PPARα signalling pathway. Particularly, we found that ELE directly binds to PPARα protein, preventing its degradation via K48‐linked polyubiquitination. Notably, the protective effects of ELE on MASH were abolished in the absence of PPARα. Conclusion and Implications Our studies reveal that ELE is a novel stabiliser of PPARα, effectively inhibiting its ubiquitin‐mediated degradation in MASH. By preserving the PPARα signalling pathway, ELE enhances lipid homeostasis and relieves the inflammation. Therefore, ELE holds significant potential as a therapeutic candidate for the treatment of MASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaSesquiterpenesFatty LiverNon-alcoholic Fatty Liver DiseaseAnimalsMiceMaleMice, Inbred C57BLDiet, High-FatDisease Models, AnimalHumansHepatocytes

Stichwörter der Autor:innen

HFDMASHPPARαlipid metabolismβ‐elemene

Substanzen

PPAR alphaSesquiterpenesbeta-elemenePpara protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Endocrinology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chemical Biology Research Center, Wenzhou Medical University, Wenzhou, China.
  • School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, China.

ORCID-Profile: Guang Liang

Förderung

  • Wenzhou Medical Universitity Distinguished Young Scholar Project
  • Science and Technology Plan Project of Wenzhou Municipality
  • Zhejiang Provincial Health Science and Technology Plan
  • Postdoctoral Fellowship Program of CPSF
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Xiong, Y., Luo, W., Ye, J., Cui, Y., Zheng, X., Jin, L., Lou, S., Zhang, Q., Wang, A., Fang, Y., Jin, T., Lin, M., Dong, H., Liang, G., Hu, X., & Zhu, W. (2025). β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models. British Journal of Pharmacology. https://doi.org/10.1111/bph.70161

Vancouver

Xiong Y, Luo W, Ye J, Cui Y, Zheng X, Jin L, et al. β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models. British Journal of Pharmacology. 2025. doi:10.1111/bph.70161

BibTeX
@article{Xiong2025,
  author = {Xiong, Yongqiang and Luo, Wu and Ye, Jiaxi and Cui, Yaqian and Zheng, Xiangsheng and Jin, Leiming and Lou, Shuaijie and Zhang, Qianhui and Wang, Ao and Fang, Yi and Jin, Tianyang and Lin, Mengsha and Dong, Hui and Liang, Guang and Hu, Xiang and Zhu, Weiwei},
  title = {β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70161}
}
Kostenlos starten →